Literature DB >> 22509077

Increased presence of effector lymphocytes during Helicobacter hepaticus-induced colitis.

Sarah J McCaskey1, Elizabeth A Rondini, Jonathan F Clinthorne, Ingeborg M Langohr, Elizabeth M Gardner, Jenifer I Fenton.   

Abstract

AIM: To identify and characterize drosophila mothers against decapentaplegic (SMAD)3-dependent changes in immune cell populations following infection with Helicobacter hepaticus (H. hepaticus).
METHODS: SMAD3(-/-) (n = 19) and colitis-resistant SMAD3(+/-) (n = 24) mice (8-10 wk of age) were infected with H. hepaticus and changes in immune cell populations [T lymphocytes, natural killer (NK) cells, T regulatory cells] were measured in the spleen and mesenteric lymph nodes (MsLNs) at 0 d, 3 d, 7 d and 28 d post-infection using flow cytometry. Genotype-dependent changes in T lymphocytes and granzyme B(+) cells were also assessed after 28 d in proximal colon tissue using immunohistochemistry.
RESULTS: As previously observed, SMAD3(-/-), but not SMAD3(+/-) mice, developed colitis, peaking at 4 wk post-infection. No significant changes in T cell subsets were observed in the spleen or in the MsLNs between genotypes at any time point. However, CD4(+) and CD8(+)/CD62L(lo) cells, an effector T lymphocyte population, as well as NK cells (NKp46/DX5(+)) were significantly higher in the MsLNs of SMAD3(-/-) mice at 7 d and 28 d post-infection. In the colon, a higher number of CD3(+) cells were present in SMAD3(-/-) compared to SMAD3(+/-) mice at baseline, which did not significantly change during infection. However, the number of granzyme B(+) cells, a marker of cytolytic lymphocytes, significantly increased in SMAD3(-/-) mice 28 d post-infection compared to both SMAD3(+/-) mice and to baseline values. This was consistent with more severe colitis development in these animals.
CONCLUSION: Data suggest that defects in SMAD3 signaling increase susceptibility to H. hepaticus-induced colitis through aberrant activation and/or dysregulation of effector lymphocytes.

Entities:  

Keywords:  Colitis; Colon cancer; Drosophila mothers against decapentaplegic; T lymphocytes; Transforming growth factor-β

Mesh:

Substances:

Year:  2012        PMID: 22509077      PMCID: PMC3319941          DOI: 10.3748/wjg.v18.i13.1459

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  61 in total

1.  CD25+CD4+ regulatory T cell migration requires L-selectin expression: L-selectin transcriptional regulation balances constitutive receptor turnover.

Authors:  Guglielmo M Venturi; Rochelle M Conway; Douglas A Steeber; Thomas F Tedder
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

Review 2.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

Review 3.  Transforming growth factor-beta in T-cell biology.

Authors:  Leonid Gorelik; Richard A Flavell
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

4.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells.

Authors:  C A Piccirillo; E M Shevach
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 6.  Inflammation and cancer: back to Virchow?

Authors:  F Balkwill; A Mantovani
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

7.  Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression.

Authors:  M M Yeung; S Melgar; V Baranov; A Oberg; A Danielsson; S Hammarström; M L Hammarström
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

8.  Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.

Authors:  G Monteleone; A Kumberova; N M Croft; C McKenzie; H W Steer; T T MacDonald
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

9.  Inflammation and cancer: a double-edged sword.

Authors:  Thorsten Hagemann; Frances Balkwill; Toby Lawrence
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743

10.  Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Margaret Karow; Richard A Flavell
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

View more
  2 in total

1.  Colitis-induced bone loss is gender dependent and associated with increased inflammation.

Authors:  Regina Irwin; Taehyung Lee; Vincent B Young; Narayanan Parameswaran; Laura R McCabe
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

2.  Protective Effects of ALDH1A Enzyme Inhibition on Helicobacter-Induced Colitis in Smad3-/- Mice are Associated with Altered α4ß7 Integrin Expression on Activated T Cells.

Authors:  Audrey Seamons; Michael Haenisch; Stacey Meeker; Olesya Pershutkina; Thea Brabb; Piper M Treuting; Jisun Paik
Journal:  Nutrients       Date:  2020-09-24       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.